Answers are grounded in this paper and cite their sources.
Seasonal influenza vaccine strains are selected months before the flu season begins, risking a vaccine mismatch. To that end, quickly predicting protection against newly emerged influenza strains is a public health preparedness need. Further, understanding immunological correlates of protection against mismatched targets is necessary for improving annual influenza vaccination compositions and/or platforms. Using a modified systems-predicted neutralizing antibody (SNAb) approach, we quantified predicted influenza virus neutralization responses in a human cohort pre- and post-vaccination during the 2025/2026 influenza season, during which the vaccine-mismatched H3N2 subclade K accounted for most influenza virus infections. This was done using the previous 10 years of vaccine targets, including the components of the 2025/2026 vaccination, as well as the 2026/2027 vaccine targets. We identified that H3N2 subclade K responders were predicted by baseline SNAb profiles, particularly to the H3N2 components of the 2024/2025 and 2025/2026 influenza vaccine. Systems serological analysis supported this at the multivariate level, with even greater accuracy in predicting mismatched responses from pre-vaccination humoral signatures. Lastly, we employed this approach to predict who would likely be high responders to the 2026/2027 influenza vaccine H1 component, and found that antibody features selected as predicting a strong neutralization response were disproportionately enriched for the H1 component of the 2025/2026 influenza vaccination. Our results support a model in which systems-based approaches can identify signatures predicting strong influenza vaccination responses before the influenza season begins.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: